Catheter Precision announces clinical data about VIVO to be presented

Catheter Precision (VTAK) announced that new clinical data about VIVO is available. Catheter Precision previously announced that data was compiled and presented during three different abstract sessions on its VIVO product. VIVO is a non-invasive mapping system used to identify areas of ventricular arrhythmia prior to a procedure. This new data highlights additional benefits of VIVO that include: When VIVO is used pre-procedurally, there are statistically significant differences in procedural outcomes. VIVO provides the ability to identify arrhythmia sources that could not otherwise be identified because the patient does not have frequent arrhythmias, or the patient has difficult anatomy. There was high accuracy in a new patient population that also shows successful long-term outcomes.